Sci-Tech Today: Africa
SEE OTHER BRANDS

Get your science and technology news from Africa

Sci-Tech Today: Africa: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Today: Africa.

Press releases published on May 5, 2025

XRP News: Vaultro Finance on a Mission to Build the First Tokenized Index Fund Protocol, Fully Decentralized on XRP Ledger

XRP News: Vaultro Finance on a Mission to Build the First Tokenized Index Fund Protocol, Fully Decentralized on XRP Ledger

SINGAPORE, May 05, 2025 (GLOBE NEWSWIRE) -- Vaultro Finance has officially emerged with a bold and transformative mission: to build the first tokenized index fund protocol fully decentralized on the XRP Ledger. Designed to simplify and democratize access …

Shoals Technologies Group, UGT Renewables and Sun Africa Announce Collaboration on up to 12GW of Solar Projects

Shoals Technologies Group, UGT Renewables and Sun Africa Announce Collaboration on up to 12GW of Solar Projects

PORTLAND, Tenn., May 05, 2025 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (Nasdaq: SHLS), a global leader in electrical balance of system (EBOS) solutions for the energy transition market, announced today the execution of a Memorandum of …

Vimeo Q1 2025 Shareholder Letter Available on Company's IR Site

Vimeo Q1 2025 Shareholder Letter Available on Company's IR Site

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Vimeo posted its first quarter 2025 shareholder letter on the investor relations section of its website at https://www.vimeo.com/investors. Vimeo will live stream a video conference to answer questions regarding …

Hudbay Publishes 2024 Annual Report, “Built to Grow”

Hudbay Publishes 2024 Annual Report, “Built to Grow”

TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) today announced the release of its 2024 annual report (“Annual Report”) which provides insight and transparency on key business, operating and …

Context Therapeutics Announces Chief Medical Officer Transition

Context Therapeutics Announces Chief Medical Officer Transition

PHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced Dr. Karen Smith, …

Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates

Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates

Cash runway extended into 2029 Initiation of Phase 3 ReDiscover-2 trial on track for mid-2025 Initiated Phase 1 RLY-2608 vascular malformations clinical trial in Q1 Extended cash runway expected to fully fund the Company meaningfully past topline data for …

GigaCloud Technology Inc. to Announce First Quarter 2025 Financial Results and Host Conference Call on May 12, 2025

GigaCloud Technology Inc. to Announce First Quarter 2025 Financial Results and Host Conference Call on May 12, 2025

EL MONTE, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc. (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced that it will report …

ServiceTitan to Announce Fiscal First Quarter 2026 Financial Results on June 5, 2025

ServiceTitan to Announce Fiscal First Quarter 2026 Financial Results on June 5, 2025

LOS ANGELES, May 05, 2025 (GLOBE NEWSWIRE) -- ServiceTitan, Inc. (Nasdaq: TTAN), the software platform that powers the trades, today announced that it will report its financial results for the fiscal first quarter ended April 30, 2025 after market close on …

Mineralys Therapeutics to Announce First Quarter 2025 Financial Results and Host Conference Call on Monday, May 12, 2025

Mineralys Therapeutics to Announce First Quarter 2025 Financial Results and Host Conference Call on Monday, May 12, 2025

RADNOR, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA) and …

FibroGen to Report First Quarter 2025 Financial Results

FibroGen to Report First Quarter 2025 Financial Results

SAN FRANCISCO, May 05, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce first quarter 2025 financial results on Monday, May 12 after the markets close. FibroGen will also conduct a conference call on that day at 5:00 PM Eastern Time  …

EverQuote Announces First Quarter 2025 Financial Results

EverQuote Announces First Quarter 2025 Financial Results

First Quarter Revenue Growth of 83% Year-Over-Year to $166.6 million First Quarter Variable Marketing Dollars Increase of 52% Year-Over-Year to $46.9 million Delivers First Quarter Net Income of $8.0 million and Record Adjusted EBITDA of $22.5 million …

Biomea Fusion Reports First Quarter 2025 Financial Results and Corporate Highlights

Biomea Fusion Reports First Quarter 2025 Financial Results and Corporate Highlights

Company Announces Strategic Realignment to Focus on Core Programs and Extend Cash Runway Icovamenib progressing toward the next phase of clinical development in insulin deficient type 2 diabetes patients and patients that are currently uncontrolled on a …

Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results

Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results

MINNEAPOLIS, May 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the …

ORIC® Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Updates

ORIC® Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Updates

Announced focused registrational clinical development plans for lead programs, extended cash runway, and accelerated/augmented corporate milestones Presented preclinical data supporting potential best-in-class profile of ORIC-944 in combination with AR …

uniQure to Announce First Quarter 2025 Financial Results

uniQure to Announce First Quarter 2025 Financial Results

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, May 05, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs will report first quarter 2025 financial …

AvePoint to Participate in May Investor Conferences 

AvePoint to Participate in May Investor Conferences 

JERSEY CITY, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT), the global leader in data security, governance and resilience, today announced that members of the Company’s executive management team will present at the following investor …

red violet to Participate in the 20th Annual Needham Technology, Media, & Consumer Conference

red violet to Participate in the 20th Annual Needham Technology, Media, & Consumer Conference

BOCA RATON, Fla., May 05, 2025 (GLOBE NEWSWIRE) -- Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced that it will participate in the 20th Annual Needham Technology, Media, …

Immuneering Reports First Quarter 2025 Financial Results and Provides Business Updates

Immuneering Reports First Quarter 2025 Financial Results and Provides Business Updates

- Progression-free survival data from more than 30 patients with first line pancreatic cancer in the ongoing Phase 2a trial of IMM-1-104 trial planned for announcement in 2Q’25 - - Reported positive data from the Company’s ongoing Phase 2a trial of lead …

ARRAY Technologies Enhances ARRAY STI H250™ Tracker with SmarTrack® Backtracking and Diffuse Capabilities

ARRAY Technologies Enhances ARRAY STI H250™ Tracker with SmarTrack® Backtracking and Diffuse Capabilities

ALBUQUERQUE, N.M., May 05, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading global provider of solar tracking technology products, software and services, today announced the expansion of its SmarTrack® …

Celldex Presents Histology Data from Phase 2 Study of Barzolvolimab in EoE Supporting Potential of Mast Depleting Agent in this Difficult to Treat Disease

Celldex Presents Histology Data from Phase 2 Study of Barzolvolimab in EoE Supporting Potential of Mast Depleting Agent in this Difficult to Treat Disease

HAMPTON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Celldex announced today the presentation of histology data from the Company’s ongoing Phase 2 study of barzolvolimab in eosinophilic esophagitis (EoE). Biopsies taken during screening demonstrate the presence …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service